EVOENDO BLOGS

  The EvoEndo Single-Use Endoscopy System is a revolutionary new approach to endoscopy. For years, the medical community has relied on traditional reusable endoscopes to perform diagnostic and therapeutic procedures. However, this method has its drawbacks, including time-consuming decontamination and sterilization processes, and the potential for infections due to inadequate cleaning. The EvoEndo Single-Use Endoscopy System eliminates these concerns by providing a sterile, disposable endoscope for every patient. This system utilizes a high-quality digital video camera, LED lighting, and a flexible endoscope that can reach all parts of the body. The design of this endoscope allows for easy manipulation, making it an excellent option for complicated procedures. One of the benefits of the EvoEndo Single-Use Endoscopy System is the speed and ease of use. Because the endoscope is disposable, there is no need for time-consuming cleaning and sterilization. Instead, doctors can quickly us...

  DENVER, CO   April 18, 2023 — EvoEndo®, Inc. (“EvoEndo”) , a medical device company developing systems for unsedated Transnasal Endoscopy (TNE) , is pleased to announce that Children’s Hospital Los Angeles (CHLA) is the first care center in California to use the EvoEndo® Single-Use Endoscopy System to perform a diagnostic unsedated TNE of the Upper Gastrointestinal (GI) Tract. CHLA is the largest provider of care for children in Los Angeles County and, according to U.S. News & World Report’s 2022-23 Best Children’s Hospitals list, the top-ranked children’s hospital in California and the Pacific U.S. region. The EvoEndo® Model LE Gastroscope may provide an option for patients five and older to undergo a full transnasal esophagogastroduodenoscopy (EGD) exam with biopsies without the need for anesthesia or sedation. Some studies have shown that repeated or continued use of general anesthetics or sedative medications in young children may affect the developing brain, res...

  DENVER, CO, EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE) , is pleased to share recent decisions announced by the Centers for Medicare and Medicaid Services (CMS) in its CY 2023 Hospital Outpatient Prospective Payment System (OPPS) final rule. Based on information submitted to CMS including the cost of the EvoEndo® Model LE Single-Use Gastroscope , and its recent 510(k) FDA clearance, CMS decided to modify the APC assignments for CPT codes 0652T, 0653T and 0654T.  Effective July 1, 2023, the APC assignment for CPT 0652T (transnasal diagnostic EGD) and 0653T (transnasal EGD with biopsy) will change from APC 5301 (Level 1 Upper GI Procedures) to APC 5302 (Level 2 Upper GI Procedures).  Additionally, CPT 0654T (transnasal EGD with insertion of intraluminal tube or catheter) will be move from APC 5302 (Level 2 Upper GI Procedures) to APC 5303 (Level 3 Upper GI Procedures).1 “We thank CMS for its considerati...